Actively Recruiting

Age: 0 - 17Years
All Genders
NCT06991881

Eosinophilic Esophagitis: Towards Improved Management

Led by Oslo University Hospital · Updated on 2025-05-28

80

Participants Needed

2

Research Sites

113 weeks

Total Duration

On this page

Sponsors

O

Oslo University Hospital

Lead Sponsor

H

Helse-Bergen HF

Collaborating Sponsor

AI-Summary

What this Trial Is About

The current project aims to improve the care for children and adolescents with eosinophilic esophagitis in a collaborative effort involving pediatric units at Oslo Unversity Hospital and Helse Bergen, Norway. Existing and new non-invasive biomarkers will be explored systematically, aiming to reduce the number of endoscopies and time on restricted diet.

CONDITIONS

Official Title

Eosinophilic Esophagitis: Towards Improved Management

Who Can Participate

Age: 0 - 17Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of eosinophilic esophagitis
  • Suspected but not yet confirmed eosinophilic esophagitis
Not Eligible

You will not qualify if you...

  • Chronic severe conditions that prevent general anesthesia
  • Lack of consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Haukeland University Hospital

Bergen, Norway

Actively Recruiting

2

OsloUH

Oslo, Norway

Actively Recruiting

Loading map...

Research Team

K

Ketil Størdal, PhD

CONTACT

E

Erling Tjora, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here